Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2016 | 04-2015 | 04-2014 | 04-2013 | 04-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,064 | -9,928 | -27,254 | -1,598 | -1,899 |
| Depreciation Amortization | N/A | N/A | N/A | -6 | 14 |
| Accounts receivable | N/A | N/A | N/A | 3 | -7 |
| Accounts payable and accrued liabilities | -161 | 309 | -59 | 98 | 174 |
| Other Working Capital | -874 | 1,741 | -484 | 365 | 239 |
| Other Operating Activity | 2,752 | 3,317 | 26,242 | 749 | 1,220 |
| Operating Cash Flow | $-4,346 | $-4,560 | $-1,555 | $-390 | $-259 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 3 |
| Net Acquisitions | N/A | N/A | -51 | N/A | -874 |
| Purchase Sale Intangibles | N/A | N/A | -3,500 | -647 | N/A |
| Other Investing Activity | 0 | 0 | -3,508 | -647 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-3,559 | $-647 | $-872 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 82 | 150 | 1,194 |
| Debt Repayment | N/A | -144 | -62 | -75 | -125 |
| Common Stock Issued | 3,568 | 3,786 | 8,511 | 1,146 | 21 |
| Financing Cash Flow | $3,568 | $3,642 | $8,531 | $1,221 | $1,090 |
| Exchange Rate Effect | -1 | 2 | N/A | N/A | N/A |
| Beginning Cash Position | 2,700 | 3,617 | 199 | 16 | 57 |
| End Cash Position | 1,921 | 2,700 | 3,617 | 199 | 16 |
| Net Cash Flow | $-779 | $-917 | $3,417 | $184 | $-42 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,346 | -4,560 | -1,555 | -390 | -259 |
| Free Cash Flow | -4,346 | -4,560 | -1,555 | -390 | -259 |